Impact of Combined Oral Zinc Sulfate and Phototherapy on Serum Bilirubin Levels in the Term Neonates with Jaundice


1 School of Nursing, Social Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran

2 Social Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran

3 Department of Pediatrics, Lorestan University of Medical Sciences, Khorramabad, Iran

4 School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran


Background: Jaundice is a physiological phenomenon and common disorder in the neonatal period. Jaundice occurs in the first month of life in 60% of term and 80% of preterm neonates, leading to hospitalization. The present study aimed to determine the effect of oral zinc sulfate on serum bilirubin levels in the neonates undergoing phototherapy.
Methods: This randomized clinical trial was conducted on 90 normal term neonates aged more than 24 hours with the total serum bilirubin of 14-19 mg/dc, who were admitted to the neonatal ward of Shahid Madani Hospital in Khorramabad, Iran for uncomplicated jaundice. Based on the inclusion criteria, these infants were divided into two groups of experimental (n=45) and control (n=45) via block random allocation. Infants in the control group only received phototherapy, and the experimental group received oral sulfate zinc (5 mg b.i.d.) in addition to phototherapy. Total serum bilirubin levels were measured upon admission and 24 and 48 hours after admission.
Results: No significant differences were observed between the experimental and control groups in terms of age, gender, birth weight, hemoglobin level, reticulocyte percentage, and total serum bilirubin at the beginning of the study (P>0.05). Comparison of the bilirubin levels using repeated measures ANOVA at different times indicated significant differences in the neonatal serum values and blood cell counts between the study groups (time effect) (F=598.078; P<0.001). However, no significant difference was observed difference in the bilirubin levels between the experimental and control groups (group effect) (F=0.103; P=0.749). Additionally, the interactive time-group effect was not statistically significant.
Conclusion: Although oral zinc salts inhibit the enterohepatic circulation of bilirubin, they might not be effective in the treatment of physiological jaundice in neonates. Due to the lack of human studies on the effect of oral zinc salts, further investigation is recommended.


1. Mohammadzadeh A, Shahfarhat A, AlizadehKaseb A, Khorakian F, Ramezani M. Prophylactic effect of zinc sulphate on hyperbilirubinemia in premature very low birth weight neonates: a randomized clinical trial. Iran J Neonatol. 2014; 5(4):6-10.
 2. Mohammadzadeh A, Farhat AS, Iranpour R. Effect of clofibrate in jaundiced term newborns. Indian J Pediatr. 2005; 72(2):123-6.
 3. Hashemian S, Mohammadzadeh A, Ataee Nakhaei A. Efficacy of zinc sulfate in reducing unconjugated hyperbilirubinemia in neonates. Rev Clin Med. 2014; 1(4):229-32.
 4. Cuperus FJ, Hafkamp AM, Hulzebos CV, Verkade HJ. Pharmacological therapies for unconjugated hyperbilirubinemia. Curr Pharm Des. 2009; 15(25):2927-38.
5. Uhrikova Z, Zibolen M, Javorka K, Chladekova L, Javorka M. Hyperbilirubinemia and phototherapy in newborns: effects on cardiac autonomic control. Early Hum Dev. 2015; 91(6):351-6.
6. Kumar A, Bagri NK, Basu S, Asthana RK. Zinc supplementation for neonatal hyperbilirubinemia: a randomized controlled trial. Indian Pediatr. 2014; 51(15):375-8.
7. Ramy N, Ghany EA, Alsharany W, Nada A, Darwish RK, Rabie WA, et al. Jaundice, phototherapy and DNA damage in full-term neonates. J Perinatol. 2016; 36(2):132-6.
8. Iranpour R, Mohammadizadeh M, Nazem-Sadati SS. Comparison of two phototherapy methods (prophylactic vs therapeutic) for management of hyperbilirubinemia in very low birth weight newborns. Iran J Pediatr. 2011; 21(4):425-30.
9. Vı´tek L, Muchova L, Zelenka J, Zadinova M, Malina J. The effect of zinc salts on serum bilirubin levels in hyperbilirubinemic rats. J Pediatr Gastroenterol Nutr. 2005; 40(2):135-40.
 10. Rana N, Mishra S, Bhatnagar S, Paul V, Deorari AK, Agarwal R. Efficacy of zinc in reducing hyperbilirubinemia among at-risk neonates: a randomized, double-blind, placebo-controlled trial. Indian J Pediatr. 2011; 78(9):1073-8.
11. Méndez-Sánchez N, Roldán-Valadez E, Flores MA, Cárdenas-Vázquez R, Uribe M. Zincsalts precipitate unconjugated bilirubin in vitro and inhibit enterohepatic cycling of bilirubin in hamsters. Eur J Clin Invest. 2001; 31(9):773-80.
12. Babaei H, Hemmati M, Fallahi V, Rezaei M. Effect of oral zinc sulfate in prevention of jaundice in healthy term newborns. J Kermanshah Univ Med Sci. 2014; 17(11):680-6. (Persian)
13. Maamouri G, Boskabadi H, Mafinejad S, Bozorgnia Y, Khakshur A. Efficacy of oral zinc sulfate intake in prevention of neonatal Jaundice. Iran J Neonatol. 2013; 4(4):11-6.
 14. Bourne N, Stegall R, Montano R, Stanberry L, Milligan G. The safety and efficacy of zinc gluconate products for the common cold. Med J. 2005; 49:1181-3.
 15. American Academy of Pediatrics. Zinc lozenges ameliorate cold symptoms. AAP Grand Rounds. 2008; 19:64.
 16. Daly L, Bourke GJ. Bourke interpretation and uses of medical statistics. 5th ed. Singapore: Blackwell Science Ltd; 2007.
 17. Patton P, Rachmadi D, Sukadi A. Effect of oral zinc on hyperbilirubinemia in full term neonates. Pediatr Indonesian. 2011; 51(2):107-10.
 18. Mafinezhad S, Bayani G, Bozorgnia Y, Khodaparast M, Jodat S. Effect of oral zinc sulfate on reducing hyperbilirubinemia among newborns under 1800 gram. J North Khorasan Univ Med Sci. 2015; 7(4):897-904. (Persian)
19. Mishra S, Cheema A, Agarwal R, Deorari A, Paul V. Oral zinc for the prevention of hyperbilirubinaemia in neonates. Cochrane Database Syst Rev. 2015; 7:CD008432.